Estrella Immunopharma
ESLA
ESLA
11 hedge funds and large institutions have $560K invested in Estrella Immunopharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$69.9K |
| 2 |
HF
2
HRT Financial
New York
|
$14K |
| 3 |
3
BlackRock
New York
|
$30.2K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$242K |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$88.5K |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$43K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$4.41K |
| 3 |
3
JPMorgan Chase & Co
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $242K | 282,843 | +5,265 | +2% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $88.5K | 103,337 | +3,164 | +3% |
|
|
3
UBS Group
Zurich,
Switzerland
| $69.9K | 72,773 | +31,739 | +77% |
|
|
4
Citadel Advisors
Miami,
Florida
| $43K | 50,156 | -41,443 | -45% |
|
|
ASM
5
ATW SPAC Management
New York
| $38.4K | 40,000 | – | – |
|
|
6
BlackRock
New York
| $30.2K | 31,407 | +6,754 | +27% |
|
7
State Street
Boston,
Massachusetts
| $19.1K | 22,352 | – | – |
|
|
HF
8
HRT Financial
New York
| $14K | 17,266 | +17,266 | New |
|
|
MCP
9
Maso Capital Partners
Hong Kong
| $9.6K | 10,000 | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $4.41K | 4,593 | -1,053 | -19% |
|
11
Bank of America
Charlotte,
North Carolina
| $89 | 92 | +5 | +6% |
|
|
12
JPMorgan Chase & Co
New York
| – | – | -23 | Closed |
|